Esperion Therapeutics is a pharmaceutical company focused on creating medicines to help patients manage elevated low density lipoprotein cholesterol, a key factor in heart disease. Its main products, NEXLETOL and NEXLIZET, are designed for individuals with cardiovascular issues or specific genetic cholesterol conditions. Based in Ann Arbor, Michigan, and founded in 2008, Esperion also collaborates with other firms to expand its portfolio, including working on an innovative oral treatment for cholesterol management.
Monday's top analyst upgrades and downgrades included Block, Broadcom, CarMax, Deere, Esperion Therapeutics, Marvell Technology, MGM Resorts International, Moderna, Newmont, Vipshop and Wingstop.
Wednesday's additional top analyst upgrades and downgrades included CF Industries, Cognex, Incyte, PayPal, XPeng and Xylem.
Monday’s top analyst upgrades and downgrades included Amgen, Apple, AT&T, Chevron, Dollar General, Fastly, Ford, Hertz, Kroger, Marvell Technology, Peloton Interactive, Salesforce.com, Stitch Fix and Twitter.
Tuesday afternoon's analyst upgrades and downgrades included CRISPR, Editas, Esperion Therapeutics, Marriott Penn National Gaming and more.
Wednesday's top analyst upgrades and downgrades included Clorox, ConocoPhillips, Exxon Mobil, Ferrari, Kraft Heinz, Nvidia and Under Armour.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Monday, including Alexion Pharma, Activision Blizzard, Baker Hughes, BioMarin, and more.
24/7 Wall St. looks at some big analyst calls that we have seen so far on Thursday, including American Electric Power, Keurig Dr Pepper, Oracle, Restaurant Brands, Tesla and more.
Tuesday's top analyst upgrades and downgrades included Bilibili, Constellation Brands, FedEx, Harley-Davidson, Matador Resources, Twilio and Yandex.
Tuesday's top analyst upgrades and downgrades included Bed Bath & Beyond, Booking, Carvana, Electronic Arts, EOG Resources, Honeywell, Intercontinental Exchange, Livongo Health, Nucor, Seres Therapeutics and Sunrun.
The top analyst upgrades, downgrades and initiations for Monday included Aimmune Therapeutics, Apple, Aurora Cannabis, Dick's Sporting Goods, Halliburton, HP, JPMorgan, Lowe's, Lyft, Schlumberger and Uber Technologies.
